Biocon Biologics allots 1.97 cr equity shares to Beta Oryz
Biocon announced that the Board of Biocon Biologics (subsidiary of Biocon) has approved the allotment of 1,97,99,305 equity shares at face value of Rs. 10 each at an issue price of Rs. 280.31 per share including a premium of Rs. 270.31 per share to the Investor i.e. Beta Oryz, a wholly owned subsidiary of ADQ against investment of Rs 555 crore. Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader, Business Standard has always strived hard to provide up-to-date information and commentary o...
Source: business-standard.com